Selected research
Market Structure
Global Quetiapine Fumarate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Quetiapine Fumarate Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Quetiapine Fumarate Tablets include Teva Pharmaceuticals, Sun Pharma, Sandoz, Lupin Limited, Hunan Dongting Pharmaceutical, Hikma, Dr. Reddy's Laboratories, AstraZeneca and Alkem Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Quetiapine Fumarate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Quetiapine Fumarate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Quetiapine Fumarate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Quetiapine Fumarate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Quetiapine Fumarate Tablets Segment by Company
Teva Pharmaceuticals
Sun Pharma
Sandoz
Lupin Limited
Hunan Dongting Pharmaceutical
Hikma
Dr. Reddy's Laboratories
AstraZeneca
Alkem Laboratories
Quetiapine Fumarate Tablets Segment by Type
0.2g
0.3g
Others
Quetiapine Fumarate Tablets Segment by Application
Hospital
Clinic
Others
Quetiapine Fumarate Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Quetiapine Fumarate Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Quetiapine Fumarate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Quetiapine Fumarate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Quetiapine Fumarate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 0.2g
- 0.3g
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Teva Pharmaceuticals
- Sun Pharma
- Sandoz
- Lupin Limited
- Hunan Dongting Pharmaceutical
- Hikma
- Dr. Reddy's Laboratories
- AstraZeneca
- Alkem Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Quetiapine Fumarate Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Quetiapine Fumarate Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Quetiapine Fumarate Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Quetiapine Fumarate Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Quetiapine Fumarate Tablets Market Dynamics
- 2.1 Quetiapine Fumarate Tablets Industry Trends
- 2.2 Quetiapine Fumarate Tablets Industry Drivers
- 2.3 Quetiapine Fumarate Tablets Industry Opportunities and Challenges
- 2.4 Quetiapine Fumarate Tablets Industry Restraints
3 Quetiapine Fumarate Tablets Market by Manufacturers
- 3.1 Global Quetiapine Fumarate Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Quetiapine Fumarate Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Quetiapine Fumarate Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Quetiapine Fumarate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Quetiapine Fumarate Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Quetiapine Fumarate Tablets Manufacturers, Product Type & Application
- 3.7 Global Quetiapine Fumarate Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Quetiapine Fumarate Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Quetiapine Fumarate Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Quetiapine Fumarate Tablets Tier 1, Tier 2, and Tier 3
4 Quetiapine Fumarate Tablets Market by Type
- 4.1 Quetiapine Fumarate Tablets Type Introduction
- 4.1.1 0.2g
- 4.1.2 0.3g
- 4.1.3 Others
- 4.2 Global Quetiapine Fumarate Tablets Sales by Type
- 4.2.1 Global Quetiapine Fumarate Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Quetiapine Fumarate Tablets Sales by Type (2021-2032)
- 4.2.3 Global Quetiapine Fumarate Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Quetiapine Fumarate Tablets Revenue by Type
- 4.3.1 Global Quetiapine Fumarate Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Quetiapine Fumarate Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Quetiapine Fumarate Tablets Revenue Market Share by Type (2021-2032)
5 Quetiapine Fumarate Tablets Market by Application
- 5.1 Quetiapine Fumarate Tablets Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Quetiapine Fumarate Tablets Sales by Application
- 5.2.1 Global Quetiapine Fumarate Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Quetiapine Fumarate Tablets Sales by Application (2021-2032)
- 5.2.3 Global Quetiapine Fumarate Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Quetiapine Fumarate Tablets Revenue by Application
- 5.3.1 Global Quetiapine Fumarate Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Quetiapine Fumarate Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Quetiapine Fumarate Tablets Revenue Market Share by Application (2021-2032)
6 Global Quetiapine Fumarate Tablets Sales by Region
- 6.1 Global Quetiapine Fumarate Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Quetiapine Fumarate Tablets Sales by Region (2021-2032)
- 6.2.1 Global Quetiapine Fumarate Tablets Sales by Region (2021-2026)
- 6.2.2 Global Quetiapine Fumarate Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Quetiapine Fumarate Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Quetiapine Fumarate Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Quetiapine Fumarate Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Quetiapine Fumarate Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Quetiapine Fumarate Tablets Revenue by Region
- 7.1 Global Quetiapine Fumarate Tablets Revenue by Region
- 7.1.1 Global Quetiapine Fumarate Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Quetiapine Fumarate Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Quetiapine Fumarate Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Quetiapine Fumarate Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Quetiapine Fumarate Tablets Revenue (2021-2032)
- 7.2.2 North America Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Quetiapine Fumarate Tablets Revenue (2021-2032)
- 7.3.2 Europe Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Quetiapine Fumarate Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Quetiapine Fumarate Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva Pharmaceuticals
- 8.1.1 Teva Pharmaceuticals Company Information
- 8.1.2 Teva Pharmaceuticals Business Overview
- 8.1.3 Teva Pharmaceuticals Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceuticals Quetiapine Fumarate Tablets Product Portfolio
- 8.1.5 Teva Pharmaceuticals Recent Developments
- 8.2 Sun Pharma
- 8.2.1 Sun Pharma Company Information
- 8.2.2 Sun Pharma Business Overview
- 8.2.3 Sun Pharma Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sun Pharma Quetiapine Fumarate Tablets Product Portfolio
- 8.2.5 Sun Pharma Recent Developments
- 8.3 Sandoz
- 8.3.1 Sandoz Company Information
- 8.3.2 Sandoz Business Overview
- 8.3.3 Sandoz Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sandoz Quetiapine Fumarate Tablets Product Portfolio
- 8.3.5 Sandoz Recent Developments
- 8.4 Lupin Limited
- 8.4.1 Lupin Limited Company Information
- 8.4.2 Lupin Limited Business Overview
- 8.4.3 Lupin Limited Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Lupin Limited Quetiapine Fumarate Tablets Product Portfolio
- 8.4.5 Lupin Limited Recent Developments
- 8.5 Hunan Dongting Pharmaceutical
- 8.5.1 Hunan Dongting Pharmaceutical Company Information
- 8.5.2 Hunan Dongting Pharmaceutical Business Overview
- 8.5.3 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Product Portfolio
- 8.5.5 Hunan Dongting Pharmaceutical Recent Developments
- 8.6 Hikma
- 8.6.1 Hikma Company Information
- 8.6.2 Hikma Business Overview
- 8.6.3 Hikma Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Hikma Quetiapine Fumarate Tablets Product Portfolio
- 8.6.5 Hikma Recent Developments
- 8.7 Dr. Reddy's Laboratories
- 8.7.1 Dr. Reddy's Laboratories Company Information
- 8.7.2 Dr. Reddy's Laboratories Business Overview
- 8.7.3 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Product Portfolio
- 8.7.5 Dr. Reddy's Laboratories Recent Developments
- 8.8 AstraZeneca
- 8.8.1 AstraZeneca Company Information
- 8.8.2 AstraZeneca Business Overview
- 8.8.3 AstraZeneca Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 AstraZeneca Quetiapine Fumarate Tablets Product Portfolio
- 8.8.5 AstraZeneca Recent Developments
- 8.9 Alkem Laboratories
- 8.9.1 Alkem Laboratories Company Information
- 8.9.2 Alkem Laboratories Business Overview
- 8.9.3 Alkem Laboratories Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Alkem Laboratories Quetiapine Fumarate Tablets Product Portfolio
- 8.9.5 Alkem Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Quetiapine Fumarate Tablets Value Chain Analysis
- 9.1.1 Quetiapine Fumarate Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Quetiapine Fumarate Tablets Production Mode & Process
- 9.2 Quetiapine Fumarate Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Quetiapine Fumarate Tablets Distributors
- 9.2.3 Quetiapine Fumarate Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst